HIV-associated Lipodystrophy Market 2025: Industry Developments, Future Growth, Share & Industry Insights | Theratechnologies Inc., Amryt Pharmaceuticals, Inc., Fawn Incorporation, Abbott Healthcare

Global HIV-associated Lipodystrophy Market reached US$ 174.90 million in 2022 and is expected to reach US$ 228.11 million by 2030, growing with a CAGR of 3.4% during the forecast period 2023-2030.

Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/hiv-associated-lipodystrophy-market?sg

Industry Latest News 2025:

✅ 2025-03-25 - FDA approved EGRIFTA WRTM (tesamorelin F8) for reduction of excess visceral abdominal fat in adults with HIV-associated lipodystrophy.

✅ 2025-04-08 - FDA approved a Prior Approval Supplement related to the F8 formulation (company announcement confirming regulatory pathway to replace EGRIFTA SV®).

✅ 2025-07-02 - Theratechnologies entered a definitive agreement to be acquired by CB Biotechnology (affiliate of Future Pak) a $254M takeover/merger transaction announced in July 2025.

✅ 2025-09-05 - Company announced commercial availability plans / U.S. availability messaging for EGRIFTA WRTM (availability/launch communications during 2025).

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/hiv-associated-lipodystrophy-market?sg

Major Key Players: Theratechnologies Inc., Amryt Pharmaceuticals, Inc., Fawn Incorporation, Abbott Healthcare Solutions, Lupin Pharmaceuticals, Inc., Pfizer Inc., Bayer Inc., AstraZeneca, Novartis Pharmaceuticals Corporation, AbbVie, Galderma Laboratories, L.P. and GlaxoSmithKline.

Market Growth Drivers:

✅ Rising HIV Prevalence and Longer Life Expectancy:
The global HIV population continues to grow, with patients living longer due to effective ART regimens. This has increased the occurrence of lipodystrophy as a chronic metabolic side effect, fueling demand for management solutions.

✅ Advances in Antiretroviral Therapy:
While modern ART has reduced toxicity, older regimens continue to affect many patients, creating a sustained need for corrective treatments and supportive care for lipodystrophy.

✅ Increasing Awareness and Diagnosis Rates:
Improved patient monitoring and awareness campaigns have enhanced recognition of lipodystrophy symptoms, encouraging earlier intervention and driving market growth.

✅ R&D and Product Innovation:
Ongoing research into mitochondrial function, fat redistribution, and metabolic pathways is leading to new therapeutic candidates and treatment protocols aimed at mitigating lipodystrophy-related complications.

✅ Government and NGO Support:
Programs by global health organizations to provide access to comprehensive HIV care-beyond viral suppression-are expanding market opportunities for metabolic disorder management among HIV patients.

Segments Covered in the HIV-associated Lipodystrophy Market:

By Type (Drug Treatment, Cosmetic Corrective Treatment)

By Route of Administration, Ophthalmology Oral, Injectables, Others)

By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Regional Analysis for HIV-associated Lipodystrophy Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Buy Now & Get 30% OFF - Grab 50% OFF on 2+ reports: https://www.datamintelligence.com/buy-now-page?report=hiv-associated-lipodystrophy-market

Chapter Outline:

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, HIV-associated Lipodystrophy market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global HIV-associated Lipodystrophy Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The global HIV-associated Lipodystrophy market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the HIV-associated Lipodystrophy Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlimited Insights. One Subscription: https://www.datamintelligence.com/reports-subscription

Frequently asked questions:

➠ What is the global sales value, production value, consumption value, import and export of HIV-associated Lipodystrophy market?

➠ Who are the global key manufacturers of the HIV-associated Lipodystrophy Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)?

➠ What are the HIV-associated Lipodystrophy market opportunities and threats faced by the vendors in the global HIV-associated Lipodystrophy Industry?

➠ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?

➠ What focused approach and constraints are holding the HIV-associated Lipodystrophy market?

➠ What are the different sales, marketing, and distribution channels in the global industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.